SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,319 | -41.7% | 13,249 | +4.0% | 0.00% | -60.0% |
| Q4 2022 | $39,985 | +471.2% | 12,734 | +848.9% | 0.01% | +400.0% |
| Q3 2022 | $7,000 | -56.2% | 1,342 | -65.5% | 0.00% | -50.0% |
| Q2 2022 | $16,000 | +1500.0% | 3,892 | +2287.7% | 0.00% | – |
| Q1 2022 | $1,000 | – | 163 | +83.1% | 0.00% | – |
| Q1 2020 | $0 | – | 89 | +50.8% | 0.00% | – |
| Q4 2019 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 59 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 59 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 59 | -88.5% | 0.00% | -100.0% |
| Q1 2018 | $9,000 | +12.5% | 514 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | +14.3% | 514 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | +75.0% | 514 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $4,000 | +100.0% | 514 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $2,000 | – | 514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WASATCH ADVISORS LP | 17,986,781 | $10,788,471 | 0.07% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 254,257 | $12,790 | 0.03% |
| Long Focus Capital Management, LLC | 1,372,000 | $822,926 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 559,731 | $336 | 0.03% |
| Rokos Capital Management LLP | 6,474,348 | $3,940,936 | 0.03% |
| Golden State Equity Partners | 166,265 | $99,726 | 0.03% |
| State of Wyoming | 92,360 | $55,398 | 0.01% |
| ExodusPoint Capital Management, LP | 1,890,425 | $1,134 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 2,927,769 | $1,753 | 0.01% |
| Fort Sheridan Advisors LLC | 53,831 | $32,288 | 0.01% |